Lattice Biologics Stock Today
| LBLTF Stock | USD 0.0001 0.00 0.00% |
Performance0 of 100
| Odds Of DistressLess than 23
|
Lattice Biologics is trading at 1.0E-4 as of the 24th of April 2024. This is a No Change since the beginning of the trading day. The stock's lowest day price was 1.0E-4. Lattice Biologics has about a 23 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. Equity ratings for Lattice Biologics are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 5th of May 2022 and ending today, the 24th of April 2024. Click here to learn more.
Lattice Biologics Ltd., a biotech company, develops, manufactures, and markets biologic products for use in the field of bone regeneration in dental, spine, and general orthopedic indications worldwide. Its products are used in a range of applications, including enhancing fusion in spine surgery and breast reconstruction post mastectomy, promotion of bone regeneration in foot and ankle surgery, promotion of skull healing following neurosurgery, enhancing wound repair in burn victims, hernia repair, and subchondral bone defect repair in knee and other joint surgeries, as well as sports medicine indications, such as anterior and posterior cruciate ligament repair. The company has 128.22 M outstanding shares. More on Lattice Biologics
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Lattice Pink Sheet Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Lattice Biologics' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Lattice Biologics or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Pres Chairman | Guy Cook |
| Business Concentration | Health Care, Biotechnology, Medical Devices, Healthcare (View all Sectors) |
Lattice Biologics [LBLTF] is a Pink Sheet which is traded between brokers as part of OTC trading. The company currently falls under 'Nano-Cap' category with a current market capitalization of 4.07 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Lattice Biologics's market, we take the total number of its shares issued and multiply it by Lattice Biologics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Lattice Biologics classifies itself under Biotechnology sector and is part of Health Care industry. The entity has 128.22 M outstanding shares.
Lattice Biologics has accumulated about 24.19 K in cash with 536.15 K of positive cash flow from operations.
Check Lattice Biologics Probability Of Bankruptcy
Ownership AllocationLattice Biologics holds a total of 128.22 Million outstanding shares. Roughly 98.0 % of Lattice Biologics outstanding shares are held by general public with 2.31 pct. owned by insiders and only 0.0 % by institutional investors. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check Lattice Ownership Details
Lattice Stock Against Markets
Picking the right benchmark for Lattice Biologics pink sheet is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Lattice Biologics pink sheet price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Lattice Biologics is critical whether you are bullish or bearish towards Lattice Biologics at a given time. Please also check how Lattice Biologics' historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Lattice Biologics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Stock Screener Now
Stock ScreenerFind equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |
| All Next | Launch Module |
Lattice Biologics Corporate Directors
Lattice Biologics corporate directors refer to members of a Lattice Biologics board of directors. The board of directors generally takes responsibility for the Lattice Biologics' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Lattice Biologics' board members must vote for the resolution. The Lattice Biologics board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Peter Wong | Independent Director | Profile | |
| John Greig | Independent Director | Profile | |
| Rupert Legge | Director | Profile | |
| Kevin Loud | Director | Profile |
How to buy Lattice Pink Sheet?
Before investing in Lattice Biologics, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Lattice Biologics. To buy Lattice Biologics stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Lattice Biologics. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Lattice Biologics stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Lattice Biologics stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Lattice Biologics stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Lattice Biologics, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.
Already Invested in Lattice Biologics?
The danger of trading Lattice Biologics is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Lattice Biologics is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Lattice Biologics. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Lattice Biologics is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lattice Biologics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Complementary Tools for Lattice Pink Sheet analysis
When running Lattice Biologics' price analysis, check to measure Lattice Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lattice Biologics is operating at the current time. Most of Lattice Biologics' value examination focuses on studying past and present price action to predict the probability of Lattice Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lattice Biologics' price. Additionally, you may evaluate how the addition of Lattice Biologics to your portfolios can decrease your overall portfolio volatility.
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |